Mitomycin C
别名: Ametycine 中文名称：
此产品请避光密封保存。
Mitomycin C (Ametycine) 是一种抗肿瘤类抗生素，通过抑制DNA合成发挥作用，用于治疗各种癌症。Mitomycin C 可诱导半胱氨酸蛋白酶依赖性和Fas/CD95非依赖性的 apoptosis。此产品为危化品（急性毒性/易燃/皮肤腐蚀），请在穿戴防护面罩、防护手套和防护服后使用。 已取得危险化学品经营许可
Mitomycin C Chemical Structure
CAS: 50-07-7
产品质控
批次：
纯度：
99.37%
99.37
Mitomycin C相关产品
细胞实验数据示例
| 细胞系 | 实验类型 | 给药浓度 | 孵育时间 | 活性描述 | 文献信息 |
|---|---|---|---|---|---|
| IE | Antiproliferative assay | 72 hrs | Antiproliferative activity against human IE cells after 72 hrs by trypan blue exclusion assay, EC50 = 1.46 μM. | 19674905 | |
| SVCT-M12 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human SVCT-M12 cells after 72 hrs by trypan blue exclusion assay, EC50 = 0.96 μM. | 19674905 | |
| MCF7 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human MCF7 cells after 72 hrs by trypan blue exclusion assay, EC50 = 0.96 μM. | 19674905 | |
| Hs888Lu | Antiproliferative assay | 72 hrs | Antiproliferative activity against human Hs888Lu cells after 72 hrs by trypan blue exclusion assay, EC50 = 0.56 μM. | 19674905 | |
| A549 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human A549 cells after 72 hrs by trypan blue exclusion assay, EC50 = 0.43 μM. | 19674905 | |
| PC3 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human PC3 cells after 72 hrs by trypan blue exclusion assay, EC50 = 0.14 μM. | 19674905 | |
| SMMC7721 | Cytotoxicity assay | 48 hrs | Cytotoxicity against human SMMC7721 cells after 48 hrs by SRB assay, IC50 = 5.4 μM. | 19432411 | |
| HeLa | Cytotoxicity assay | 48 hrs | Cytotoxicity against human HeLa cells after 48 hrs by SRB assay, IC50 = 3.3 μM. | 19432411 | |
| HL60 | Cytotoxicity assay | 48 hrs | Cytotoxicity against human HL60 cells after 48 hrs by SRB assay, IC50 = 1.5 μM. | 19432411 | |
| HCT8 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human HCT8 cells after 72 hrs by SRB assay, IC90 = 5.7 μM. | 18845441 | |
| HCT8 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human HCT8 cells after 72 hrs by SRB assay, IC50 = 0.083 μM. | 18845441 | |
| A549 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human A549 cells after 72 hrs by Alamar Blue assay, IC50 = 0.4 μM. | 18752870 | |
| MCF7 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human MCF7 cells after 72 hrs by Alamar Blue assay, IC50 = 0.2 μM. | 18752870 | |
| BAC29 | Cytotoxicity assay | 3 days | Cytotoxicity against BRCA2-proficient Chinese hamster BAC29 mutant cells after 3 days by WST1 cell viability assay, IC50 = 0.4 μM. | 18505284 | |
| V-C8 | Cytotoxicity assay | 3 days | Cytotoxicity against BRCA2-deficient Chinese hamster V-C8 mutant cells after 3 days by WST1 cell viability assay, IC50 = 0.005 μM. | 18505284 | |
| HT29 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human HT29 cells after 72 hrs by MTT assay in presence of 2 uM dicoumarol, IC50 = 2.1 μM. | 18222567 | |
| HT29 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human HT29 cells after 72 hrs by MTT assay, IC50 = 0.9 μM. | 18222567 | |
| MCF7 | Cytotoxicity assay | 24 hrs | Cytotoxicity against human MCF7 cells after 24 hrs, IC50 = 5 μM. | 18037301 | |
| A549 | Cytotoxicity assay | 24 hrs | Cytotoxicity against human A549 cells after 24 hrs, IC50 = 4.5 μM. | 18037301 | |
| MCF7 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human MCF7 cells after 72 hrs, IC50 = 1.2 μM. | 18037301 | |
| A549 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human A549 cells after 72 hrs, IC50 = 0.24 μM. | 18037301 | |
| MCF7 | Cytotoxicity assay | 3 days | Cytotoxicity against human MCF7 cells after 3 days by SRB assay, IC50 = 1.5 μM. | 16038545 | |
| HCT8 | Cytotoxicity assay | 3 days | Cytotoxicity against human HCT8 cells after 3 days by SRB assay, IC50 = 0.6 μM. | 16038545 | |
| KB | Cytotoxicity assay | 3 days | Cytotoxicity against human KB cells after 3 days by SRB assay, IC50 = 0.6 μM. | 16038545 | |
| A549 | Cytotoxicity assay | 3 days | Cytotoxicity against human A549 cells after 3 days by SRB assay, IC50 = 0.3 μM. | 16038545 | |
| HeLa | Cytotoxicity assay | 5 to 8 days | Cytotoxicity against human HeLa cells assessed as inhibition of colony formation after 5 to 8 days by colony assay, IC50 = 0.068 μM. | 11975488 | |
| EMT6 | Function assay | 1 hr | Compound is measured for surviving fractions of EMT6 tumor cells treated in culture with (0.50 uM) concentration for 1 hr under aerobic condition., ED50 = 0.7 μM. | 7452674 | |
| EMT6 | Function assay | 1 hr | Compound is measured for surviving fractions of EMT6 tumor cells treated in culture with (0.50 uM) concentration for 1 hr under hypoxic condition., ED50 = 0.001 μM. | 7452674 | |
| L1210 | Growth inhibition assay | 1 hr | Inhibition of L1210 leukemia cells, after exposure to compound for period of 1 hr, ID50 = 3.1 μM. | 3397995 | |
| L1210 | Growth inhibition assay | 8-9 hrs | Inhibition of L1210 leukemia cells, after exposure to compound for period of 8-9 hr, ID50 = 0.18 μM. | 3397995 | |
| AA8 | Function assay | 4 hrs | Inhibitory activity of compound for AA8 cells to reduce cell density by 50% (exposed to compound for 4 hours), IC50 = 0.00108 μM. | 2909741 | |
| P388 | Antiproliferative assay | 48 hrs | Antiproliferative activity against mouse P388 cells after 48 hrs by MTT assay, IC50 = 3 μM. | 2778449 | |
| HT-29 | Antiproliferative assay | 96 hrs | Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay, IC50 = 0.099 μM. | 2778449 | |
| Human Caki-1 Renal CellCarcinoma Cell | Function assay | 96 h | Inhibitory concentration against Human Caki-1 Renal CellCarcinoma Cell Lines (CD70+) at 96th hour, ic50=40 nM | 15743178 | |
| human colon cancer cell line HCT15 | Cytotoxic assay | 72 h | In vitro cytotoxic activity against human colon cancer cell line HCT15 after 72 hr of drug exposure determined by the SRB assay, IC50=70 nM | 14980672 | |
| MPC5 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human MPC5 cells after 72 hrs by trypan blue exclusion assay, EC50 = 2.1 μM. | 19674905 | |
| PC3 | Growth inhibition assay | 48 hrs | Growth inhibition of human PC3 cells after 48 hrs by sulforhodamine B assay, IC50 = 1.5 μM. | 19939522 | |
| Hep2 | Growth inhibition assay | 48 hrs | Growth inhibition of human Hep2 cells after 48 hrs by sulforhodamine B assay, IC50 = 1.5 μM. | 19939522 | |
| Daudi | Growth inhibition assay | 24 to 72 hrs | Growth inhibition of human Daudi cells after 24 to 72 hrs by MTT assay, IC50 = 0.45 μM. | 20117936 | |
| K562 | Growth inhibition assay | 24 to 72 hrs | Growth inhibition of human K562 cells after 24 to 72 hrs by MTT assay, IC50 = 0.47 μM. | 20117936 | |
| K562-Lucena 1 | Growth inhibition assay | 24 to 72 hrs | Growth inhibition of human K562-Lucena 1 cells after 24 to 72 hrs by MTT assay, IC50 = 2.75 μM. | 20117936 | |
| PBMC | Growth inhibition assay | 24 to 72 hrs | Growth inhibition of phytohemagglutinin-activated human PBMC cells after 24 to 72 hrs by MTT assay, IC50 = 4.03 μM. | 20117936 | |
| GM00637 | Cytotoxicity assay | 24 hrs | Cytotoxicity against human GM00637 cells after 24 hrs by MTT assay, IC50 = 0.9 μM. | 20122765 | |
| DU145 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human DU145 cells after 72 hrs by MTT assay, IC50 = 0.17 μM. | 20605274 | |
| HeLa | Cytotoxicity assay | 72 hrs | Cytotoxicity against human HeLa cells after 72 hrs by MTT assay, IC50 = 0.27 μM. | 20605274 | |
| GM00637 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human GM00637 cells after 72 hrs by MTT assay, IC50 = 0.46 μM. | 20605274 | |
| DU145 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human DU145 cells assessed as reduction in mean cell viability after 72 hrs by MTT assay, IC50 = 0.17 μM. | 22522008 | |
| HeLa | Cytotoxicity assay | 72 hrs | Cytotoxicity against human HeLa cells assessed as reduction in mean cell viability after 72 hrs by MTT assay, IC50 = 0.27 μM. | 22522008 | |
| GM00637 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human GM00637 cells assessed as reduction in mean cell viability after 72 hrs by MTT assay, IC50 = 0.46 μM. | 22522008 | |
| HL60 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human HL60 cells after 72 hrs by WST8 assay, IC50 = 0.1 μM. | 22537363 | |
| HL60 | Cytotoxicity assay | 48 hrs | Cytotoxicity against human HL60 cells after 48 hrs by SRB assay, IC50 = 1.8 μM. | 22642381 | |
| HeLa | Cytotoxicity assay | 48 hrs | Cytotoxicity against human HeLa cells after 48 hrs by SRB assay, IC50 = 3.4 μM. | 22642381 | |
| SMMC7721 | Cytotoxicity assay | 48 hrs | Cytotoxicity against human SMMC7721 cells after 48 hrs by SRB assay, IC50 = 5.6 μM. | 22642381 | |
| A549 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human A549 cells after 72 hrs by alamar blue assay, IC50 = 0.4 μM. | 23123017 | |
| HCT116 | Antiproliferative assay | 48 hrs | Antiproliferative activity against human HCT116 cells after 48 hrs by sulforhodamine B assay, IC50 = 0.5 μM. | 23501113 | |
| NCI-H23 | Cytotoxicity assay | 48 hrs | Cytotoxicity against human NCI-H23 cells after 48 hrs by MTT assay, IC50 = 2 μM. | 23792352 | |
| SPCA1 | Cytotoxicity assay | 48 hrs | Cytotoxicity against human SPCA1 cells after 48 hrs by MTT assay, IC50 = 1.68 μM. | 23999045 | |
| SGC7901 | Cytotoxicity assay | 48 hrs | Cytotoxicity against human SGC7901 cells after 48 hrs by MTT assay, IC50 = 2.05 μM. | 23999045 | |
| PC3 | Cytotoxicity assay | 48 hrs | Cytotoxicity against human PC3 cells after 48 hrs by SRB assay, IC50 = 1.5 μM. | 24056146 | |
| HeLa | Cytotoxicity assay | 48 hrs | Cytotoxicity against human HeLa cells after 48 hrs by SRB assay, IC50 = 2 μM. | 24056146 | |
| MDA-MB-231 | Cytotoxicity assay | 5 days | Cytotoxicity against human MDA-MB-231 cells overexpressing DT-diaphorase after 5 days, EC50 = 0.103 μM. | 24436995 | |
| MDA-MB-231 | Cytotoxicity assay | 5 days | Cytotoxicity against wild-type human MDA-MB-231 cells after 5 days, EC50 = 1.25 μM. | 24436995 | |
| HCT15 | Cytotoxicity assay | 48 hrs | Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay, IC50 = 0.5 μM. | 24910974 | |
| HeLa | Cytotoxicity assay | 48 hrs | Cytotoxicity against human HeLa cells after 48 hrs by SRB method, IC50 = 3 μM. | 24913558 | |
| SMMC-7221 | Cytotoxicity assay | 48 hrs | Cytotoxicity against human SMMC-7221 cells after 48 hrs by SRB method, IC50 = 3 μM. | 24913558 | |
| HL60 | Cytotoxicity assay | 48 hrs | Cytotoxicity against human HL60 cells after 48 hrs by SRB method, IC50 = 3 μM. | 24913558 | |
| PC3 | Cytotoxicity assay | 48 hrs | Cytotoxicity against human PC3 cells after 48 hrs by SRB assay, IC50 = 1.5 μM. | 25176329 | |
| HeLa | Cytotoxicity assay | 48 hrs | Cytotoxicity against human HeLa cells after 48 hrs by SRB assay, IC50 = 2 μM. | 25176329 | |
| A549 | Cytotoxicity assay | 48 hrs | Cytotoxicity against human A549 cells after 48 hrs by SRB assay, IC50 = 0.04 μM. | 25259515 | |
| THP1 | Cytotoxicity assay | 48 hrs | Cytotoxicity against human THP1 cells after 48 hrs by SRB assay, IC50 = 0.1 μM. | 25259515 | |
| MCF7 | Cytotoxicity assay | 48 hrs | Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay, IC50 = 0.2 μM. | 25259515 | |
| A549 | Cytotoxicity assay | 24 hrs | Cytotoxicity against human A549 cells assessed as reduction in cell viability after 24 hrs by WST8 assay, IC50 = 0.45 μM. | 25442306 | |
| SF539 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human SF539 cells after 72 hrs by MTS assay, IC50 = 0.038 μM. | 26335269 | |
| M14 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human M14 cells after 72 hrs by MTS assay, IC50 = 0.47 μM. | 26335269 | |
| MDA-MB-468 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human MDA-MB-468 cells after 72 hrs by MTS assay, IC50 = 0.5 μM. | 26335269 | |
| SF295 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human SF295 cells after 72 hrs by MTS assay, IC50 = 0.54 μM. | 26335269 | |
| NCI-H226 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human NCI-H226 cells after 72 hrs by MTS assay, IC50 = 0.58 μM. | 26335269 | |
| A549 | Cytotoxicity assay | 48 hrs | Cytotoxicity against human A549 cells assessed as decrease in cell viability at 10 to 100 uM after 48 hrs by SRB assay, EC50 = 5.2 μM. | 26508550 | |
| HUT78 | Antiproliferative assay | 48 hrs | Antiproliferative activity against human HUT78 cells after 48 hrs by resazurin reduction assay, IC50 = 0.066 μM. | 26541587 | |
| Jurkat T | Antiproliferative assay | 48 hrs | Antiproliferative activity against human Jurkat T cells in hypoxic condition after 48 hrs by resazurin reduction assay, IC50 = 0.303 μM. | 26541587 | |
| HL60 | Antiproliferative assay | 48 hrs | Antiproliferative activity against human HL60 cells after 48 hrs by resazurin reduction assay, IC50 = 0.41 μM. | 26541587 | |
| Jurkat T | Antiproliferative assay | 48 hrs | Antiproliferative activity against human Jurkat T cells after 48 hrs by resazurin reduction assay, IC50 = 0.578 μM. | 26541587 | |
| HeLa | Antiproliferative assay | 48 hrs | Antiproliferative activity against human HeLa cells after 48 hrs by resazurin reduction assay, IC50 = 1.87 μM. | 26541587 | |
| HepG2 | Antiproliferative assay | 48 hrs | Antiproliferative activity against human HepG2 cells after 48 hrs by resazurin reduction assay, IC50 = 2.937 μM. | 26541587 | |
| T47D | Antiproliferative assay | 48 hrs | Antiproliferative activity against human T47D cells after 48 hrs by resazurin reduction assay, IC50 = 16.97 μM. | 26541587 | |
| PC3 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human PC3 cells after 72 hrs by CCK-8 assay, IC50 = 1.4 μM. | 26615890 | |
| A549 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human A549 cells after 72 hrs by CCK-8 assay, IC50 = 1.7 μM. | 26615890 | |
| HT-29 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human HT-29 cells expressing NQO1 after 72 hrs by MTT assay, IC50 = 7.099 μM. | 28395199 | |
| NCI-H596 | Antiproliferative assay | 72 hrs | Antiproliferative activity against NQO1 deficient human NCI-H596 cells after 72 hrs by MTT assay, IC50 = 11.969 μM. | 28395199 | |
| A549 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human A549 cells expressing NQO1 after 72 hrs by MTT assay, IC50 = 15.525 μM. | 28395199 | |
| LO2 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human LO2 cells after 72 hrs by MTT assay, IC50 = 25.023 μM. | 28395199 | |
| CHOK1 | Cytotoxicity assay | 24 hrs | Cytotoxicity against CHOK1 cells incubated for 24 hrs by MTT asasy, IC50 = 13.2 μM. | 28615134 | |
| A549 | Growth inhibition assay | 72 hrs | Growth inhibition of human A549 cells after 72 hrs by Cell-Titer Glo assay, GI50 = 0.08 μM. | 28682609 | |
| SKOV3 | Growth inhibition assay | 72 hrs | Growth inhibition of human SKOV3 cells after 72 hrs by Cell-Titer Glo assay, GI50 = 0.1 μM. | 28682609 | |
| HCT116 | Growth inhibition assay | 72 hrs | Growth inhibition of human HCT116 cells after 72 hrs by Cell-Titer Glo assay, GI50 = 0.2 μM. | 28682609 | |
| 786-O | Growth inhibition assay | 72 hrs | Growth inhibition of human 786-O cells after 72 hrs by Cell-Titer Glo assay, GI50 = 0.21 μM. | 28682609 | |
| BxPC3 | Growth inhibition assay | 72 hrs | Growth inhibition of human BxPC3 cells after 72 hrs by Cell-Titer Glo assay, GI50 = 0.38 μM. | 28682609 | |
| HEC6 | Growth inhibition assay | 72 hrs | Growth inhibition of human HEC6 cells after 72 hrs by Cell-Titer Glo assay, GI50 = 1.4 μM. | 28682609 | |
| MKN74 | Growth inhibition assay | 72 hrs | Growth inhibition of human MKN74 cells after 72 hrs by Cell-Titer Glo assay, GI50 = 1.7 μM. | 28682609 | |
| U87MG | Growth inhibition assay | 72 hrs | Growth inhibition of human U87MG cells after 72 hrs by Cell-Titer Glo assay, GI50 = 1.8 μM. | 28682609 | |
| HuH7 | Growth inhibition assay | 72 hrs | Growth inhibition of human HuH7 cells after 72 hrs by Cell-Titer Glo assay, GI50 = 2 μM. | 28682609 | |
| MCF7 | Growth inhibition assay | 72 hrs | Growth inhibition of human MCF7 cells after 72 hrs by Cell-Titer Glo assay, GI50 = 2.5 μM. | 28682609 | |
| MDA-MB-231 | Antiproliferative assay | 48 hrs | Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay, IC50 = 4.4 μM. | 29280632 | |
| HL60 | Antiproliferative assay | 48 hrs | Antiproliferative activity against human HL60 cells after 48 hrs by CCK8 assay, IC50 = 0.19 μM. | 29475587 | |
| HeLa | Antiproliferative assay | 48 hrs | Antiproliferative activity against human HeLa cells after 48 hrs by CCK8 assay, IC50 = 1.13 μM. | 29475587 | |
| Daoy | Cytotoxicity assay | Cytotoxicity against human Daoy cells by MTT assay, ED50 = 0.21 μM. | 19061391 | ||
| WiDr | Cytotoxicity assay | Cytotoxicity against human WiDr cells by MTT assay, ED50 = 0.18 μM. | 19061391 | ||
| A549 | Cytotoxicity assay | Cytotoxicity against human A549 cells by Alamar blue assay, IC50 = 0.4 μM. | 18037301 | ||
| MCF7 | Cytotoxicity assay | Cytotoxicity against human MCF7 cells by Alamar blue assay, IC50 = 0.2 μM. | 18037301 | ||
| MPC5 | Cytotoxicity assay | Cytotoxicity against human MPC5 cells assessed as cell viability by tryptan blue staining method, EC50 = 2.1 μM. | 17950604 | ||
| IE | Cytotoxicity assay | Cytotoxicity against human IE cells assessed as cell viability by tryptan blue staining method, EC50 = 1.46 μM. | 17950604 | ||
| Hc | Cytotoxicity assay | Cytotoxicity against human Hc cells assessed as cell viability by tryptan blue staining method, EC50 = 1.46 μM. | 17950604 | ||
| MCF7 | Cytotoxicity assay | Cytotoxicity against human MCF7 cells assessed as cell viability by tryptan blue staining method, EC50 = 0.96 μM. | 17950604 | ||
| Fb | Cytotoxicity assay | Cytotoxicity against human Fb cells assessed as cell viability by tryptan blue staining method, EC50 = 0.93 μM. | 17950604 | ||
| A549 | Cytotoxicity assay | Cytotoxicity against human A549 cells assessed as cell viability by tryptan blue staining method, EC50 = 0.43 μM. | 17950604 | ||
| PC3 | Cytotoxicity assay | Cytotoxicity against human PC3 cells assessed as cell viability by tryptan blue staining method, EC50 = 0.14 μM. | 17950604 | ||
| KATO III | Cytotoxicity assay | Cytotoxicity against human KATO III cells by MTT assay, ED50 = 49 μM. | 12880314 | ||
| SCL6 | Cytotoxicity assay | Cytotoxicity against human SCL6 cells by MTT assay, ED50 = 20.7 μM. | 12880314 | ||
| SCL | Cytotoxicity assay | Cytotoxicity against human SCL cells by MTT assay, ED50 = 20.2 μM. | 12880314 | ||
| NUGC4 | Cytotoxicity assay | Cytotoxicity against human NUGC4 cells by MTT assay, ED50 = 19.1 μM. | 12880314 | ||
| SCL37'6 | Cytotoxicity assay | Cytotoxicity against human SCL37'6 cells by MTT assay, ED50 = 19 μM. | 12880314 | ||
| SCL9 | Cytotoxicity assay | Cytotoxicity against human SCL9 cells by MTT assay, ED50 = 17.4 μM. | 12880314 | ||
| K562 | Function assay | In vitro inhibitory activity against K562 leukemia cells in the presence of pd2, IC50 = 0.0158 μM. | 12699386 | ||
| K562 | Function assay | In vitro inhibitory activity against K562 leukemia cells, IC50 = 0.001 μM. | 12699386 | ||
| colon cancer cell | Cytotoxicity assay | Cytotoxicity against human colon cancer cells, GI50 = 0.18 μM. | 11473418 | ||
| ovarian cancer cell | Cytotoxicity assay | Cytotoxicity against human ovarian cancer cells, GI50 = 0.12 μM. | 11473418 | ||
| stomach cancer cell | Cytotoxicity assay | Cytotoxicity against human stomach cancer cells, GI50 = 0.1 μM. | 11473418 | ||
| CNS cancer cell | Cytotoxicity assay | Cytotoxicity against human CNS cancer cells, GI50 = 0.064 μM. | 11473418 | ||
| breast cancer cell | Cytotoxicity assay | Cytotoxicity against human breast cancer cells, GI50 = 0.034 μM. | 11473418 | ||
| lung cancer cell | Cytotoxicity assay | Cytotoxicity against human lung cancer cells, GI50 = 0.023 μM. | 11473418 | ||
| MCF-7 | Antiproliferative assay | Antiproliferative activity of compound was evaluated on MCF-7 cells from human breast adenocarcinoma, ID50 = 42.92 μM. | 11012027 | ||
| Molt3 | Antiproliferative assay | Antiproliferative activity of compound was evaluated on Molt3 cells from human lymphoblastic leukemia, ID50 = 2.66 μM. | 11012027 | ||
| SupT1 | Antiproliferative assay | Antiproliferative activity of compound was evaluated on SupT1 cells from human non-Hodgkin lymphoma, ID50 = 0.7 μM. | 11012027 | ||
| aerobic cell | Function assay | In vitro concentration required to kill 50% of the aerobic cells, C50 = 0.8 μM. | 9240349 | ||
| V79-379A | Function assay | In vitro concentration required to kill hypoxic cells V79-379A cells, C50 = 0.4 μM. | 9240349 | ||
| DC-3F/AD-II | Growth inhibition assay | Inhibition of cell growth was studied in chinese hamster lung cells resistant to actinomycin D (DC-3F/AD-II)., IC50 = 0.11 μM. | 8709111 | ||
| DC-3F | Growth inhibition assay | Inhibition of cell growth was studied in chinese hamster lung cells (DC-3F), IC50 = 0.082 μM. | 8709111 | ||
| HL-60 | Growth inhibition assay | Inhibition of cell growth was studied in human promyelocytic leukemic (HL-60) cells., IC50 = 0.05 μM. | 8709111 | ||
| P388 | Function assay | Evaluation of inhibitory activity against multidrug resistant P388 cells (P388/ADR) cells, IC50 = 0.535 μM. | 8544183 | ||
| P388 | Function assay | Evaluation of inhibitory activity against drug sensitive P388 cells (P388/S) cells, IC50 = 0.048 μM. | 8544183 | ||
| HeLa S3 | Function assay | In vitro anticellular activity against HeLa S3 cells, IC50 = 0.59 μM. | 8021919 | ||
| HeLa S3 | Function assay | In vitro anticellular activity against HeLa S3 cells; 0.82-1.4, IC50 = 1.4 μM. | 8021918 | ||
| HeLa S3 | Function assay | In vitro anticellular activity against HeLa S3 cells; 0.59-1.1, IC50 = 1.1 μM. | 8021918 | ||
| V79 | Function assay | Inhibitory concentration required to kill 50% of the cells was evaluated under aerobic conditions from chinese hamster V79 cells., IC50 = 0.8 μM. | 7966141 | ||
| V79 | Function assay | Inhibitory concentration required to kill 50% of the cells was evaluated under anaerobic (N2) conditions from chinese hamster V79 cells., IC50 = 0.4 μM. | 7966141 | ||
| P388 | Antitumor assay | Antitumor potency on P388 leukemia cells in culture, IC50 = 0.0508 μM. | 1906109 | ||
| L1210 | Function assay | Inhibitory concentration on multidrug-resistant L1210 leukemia cells., IC50 = 1.5 μM. | 1906107 | ||
| L1210 | Function assay | Inhibitory concentration on parentral (sensitive) L1210 leukemia cells., IC50 = 0.09 μM. | 1906107 | ||
| HeLa | Function assay | In vitro anticellular activity against HeLa cells., IC50 = 0.81 μM. | 1495011 | ||
| WiDr colon cancer cell | Growth inhibition assay | In vitro inhibition of WiDr colon cancer cell line, IC50=10 nM | 1920349 | ||
| SW480 colon cancer cell | Growth inhibition assay | In vitro inhibition of SW480 colon cancer cell line, IC50=7 nM | 1920349 | ||
| human A2780 (ovarian) tumor cell | Cytotoxic assay | The compound was evaluated for the cytotoxicity against human A2780 (ovarian) tumor cell lines, IC50=50 nM | 10698444 | ||
| human HT-29 (colon) tumor cell | Cytotoxic assay | The compound was evaluated for the cytotoxicity against human HT-29 (colon) tumor cell lines, IC50=40 nM | 10698444 | ||
| human CH1 (ovarian) tumor cell | Cytotoxic assay | The compound was evaluated for the cytotoxicity against human CH1 (ovarian) tumor cell lines, IC50=40 nM | 10698444 | ||
| A549 | Cytotoxicity assay | Cytotoxicity against human A549 cells by MTT assay, IC50 = 3 μM. | 22545792 | ||
| A549 | Cytotoxicity assay | Cytotoxicity against human A549 cells, IC50 = 0.5 μM. | 27089214 | ||
| PC3 | Cytotoxicity assay | Cytotoxicity against human PC3 cells, IC50 = 0.5 μM. | 27089214 | ||
| NTERA-S-cl-D1 | Growth inhibition assay | IC50 = 0.0221 nM | SANGER | ||
| MOLT-4 | Growth inhibition assay | IC50 = 0.0325 nM | SANGER | ||
| J82 | Growth inhibition assay | IC50 = 0.119 nM | SANGER | ||
| 697 | Growth inhibition assay | IC50 = 0.1283 nM | SANGER | ||
| KYSE-510 | Growth inhibition assay | IC50 = 0.1486 nM | SANGER | ||
| NCI-H2170 | Growth inhibition assay | IC50 = 0.1513 nM | SANGER | ||
| BE-13 | Growth inhibition assay | IC50 = 0.1673 nM | SANGER | ||
| LC-2-ad | Growth inhibition assay | IC50 = 0.2492 nM | SANGER | ||
| IMR-5 | Growth inhibition assay | IC50 = 0.3076 nM | SANGER | ||
| EW-16 | Growth inhibition assay | IC50 = 0.31 nM | SANGER | ||
| MC-IXC | Growth inhibition assay | IC50 = 0.638 nM | SANGER | ||
| SW872 | Growth inhibition assay | IC50 = 0.676 nM | SANGER | ||
| NCI-H2228 | Growth inhibition assay | IC50 = 0.7963 nM | SANGER | ||
| NALM-6 | Growth inhibition assay | IC50 = 1.066 nM | SANGER | ||
| ES4 | Growth inhibition assay | IC50 = 1.555 nM | SANGER | ||
| KE-37 | Growth inhibition assay | IC50 = 1.636 nM | SANGER | ||
| IST-MEL1 | Growth inhibition assay | IC50 = 1.684 nM | SANGER | ||
| ES8 | Growth inhibition assay | IC50 = 1.712 nM | SANGER | ||
| MV-4-11 | Growth inhibition assay | IC50 = 1.732 nM | SANGER | ||
| 639-V | Growth inhibition assay | IC50 = 1.759 nM | SANGER | ||
| OCI-AML2 | Growth inhibition assay | IC50 = 1.886 nM | SANGER | ||
| SK-LU-1 | Growth inhibition assay | IC50 = 2.217 nM | SANGER | ||
| REH | Growth inhibition assay | IC50 = 2.548 nM | SANGER | ||
| PSN1 | Growth inhibition assay | IC50 = 2.554 nM | SANGER | ||
| SBC-5 | Growth inhibition assay | IC50 = 2.589 nM | SANGER | ||
| HT-3 | Growth inhibition assay | IC50 = 2.928 nM | SANGER | ||
| SIG-M5 | Growth inhibition assay | IC50 = 3.524 nM | SANGER | ||
| ES7 | Growth inhibition assay | IC50 = 3.653 nM | SANGER | ||
| CHP-212 | Growth inhibition assay | IC50 = 4.368 nM | SANGER | ||
| P12-ICHIKAWA | Growth inhibition assay | IC50 = 4.787 nM | SANGER | ||
| HUTU-80 | Growth inhibition assay | IC50 = 4.83 nM | SANGER | ||
| P30-OHK | Growth inhibition assay | IC50 = 4.842 nM | SANGER | ||
| NCI-H1651 | Growth inhibition assay | IC50 = 4.99 nM | SANGER | ||
| COR-L279 | Growth inhibition assay | IC50 = 5.545 nM | SANGER | ||
| CMK | Growth inhibition assay | IC50 = 5.827 nM | SANGER | ||
| MHH-CALL-2 | Growth inhibition assay | IC50 = 6.06 nM | SANGER | ||
| BV-173 | Growth inhibition assay | IC50 = 6.067 nM | SANGER | ||
| NCI-H209 | Growth inhibition assay | IC50 = 6.168 nM | SANGER | ||
| NCI-H460 | Growth inhibition assay | IC50 = 6.452 nM | SANGER | ||
| DU-145 | Growth inhibition assay | IC50 = 6.519 nM | SANGER | ||
| 769-P | Growth inhibition assay | IC50 = 7.112 nM | SANGER | ||
| ES1 | Growth inhibition assay | IC50 = 7.288 nM | SANGER | ||
| COLO-668 | Growth inhibition assay | IC50 = 7.545 nM | SANGER | ||
| NKM-1 | Growth inhibition assay | IC50 = 7.831 nM | SANGER | ||
| ES3 | Growth inhibition assay | IC50 = 7.882 nM | SANGER | ||
| SCC-3 | Growth inhibition assay | IC50 = 8.519 nM | SANGER | ||
| SU-DHL-1 | Growth inhibition assay | IC50 = 8.609 nM | SANGER | ||
| ML-2 | Growth inhibition assay | IC50 = 8.781 nM | SANGER | ||
| SF295 | Growth inhibition assay | IC50 = 11.48 nM | SANGER | ||
| EW-7 | Growth inhibition assay | IC50 = 12.14 nM | SANGER | ||
| H4 | Growth inhibition assay | IC50 = 12.44 nM | SANGER | ||
| LB2241-RCC | Growth inhibition assay | IC50 = 13.19 nM | SANGER | ||
| SR | Growth inhibition assay | IC50 = 13.46 nM | SANGER | ||
| LB1047-RCC | Growth inhibition assay | IC50 = 13.6 nM | SANGER | ||
| MCF7 | Growth inhibition assay | IC50 = 13.9 nM | SANGER | ||
| ESS-1 | Growth inhibition assay | IC50 = 13.92 nM | SANGER | ||
| NCI-H2122 | Growth inhibition assay | IC50 = 13.96 nM | SANGER | ||
| 786-0 | Growth inhibition assay | IC50 = 14.01 nM | SANGER | ||
| COLO-205 | Growth inhibition assay | IC50 = 14.33 nM | SANGER | ||
| HAL-01 | Growth inhibition assay | IC50 = 15.73 nM | SANGER | ||
| MHH-ES-1 | Growth inhibition assay | IC50 = 16.26 nM | SANGER | ||
| NUGC-3 | Growth inhibition assay | IC50 = 16.95 nM | SANGER | ||
| RPMI-8402 | Growth inhibition assay | IC50 = 17.13 nM | SANGER | ||
| ATN-1 | Growth inhibition assay | IC50 = 17.39 nM | SANGER | ||
| NCI-H441 | Growth inhibition assay | IC50 = 17.6 nM | SANGER | ||
| LB996-RCC | Growth inhibition assay | IC50 = 17.68 nM | SANGER | ||
| CAL-148 | Growth inhibition assay | IC50 = 17.83 nM | SANGER | ||
| CTV-1 | Growth inhibition assay | IC50 = 18.67 nM | SANGER | ||
| HOP-62 | Growth inhibition assay | IC50 = 20.2 nM | SANGER | ||
| CAKI-1 | Growth inhibition assay | IC50 = 23.32 nM | SANGER | ||
| PA-1 | Growth inhibition assay | IC50 = 23.51 nM | SANGER | ||
| HT-144 | Growth inhibition assay | IC50 = 23.75 nM | SANGER | ||
| LOUCY | Growth inhibition assay | IC50 = 26.19 nM | SANGER | ||
| BPH-1 | Growth inhibition assay | IC50 = 29.9 nM | SANGER | ||
| LS-1034 | Growth inhibition assay | IC50 = 30.16 nM | SANGER | ||
| 23132-87 | Growth inhibition assay | IC50 = 30.53 nM | SANGER | ||
| BB30-HNC | Growth inhibition assay | IC50 = 30.61 nM | SANGER | ||
| CAL-51 | Growth inhibition assay | IC50 = 30.86 nM | SANGER | ||
| ALL-PO | Growth inhibition assay | IC50 = 30.98 nM | SANGER | ||
| 5637 | Growth inhibition assay | IC50 = 31.93 nM | SANGER | ||
| KYSE-150 | Growth inhibition assay | IC50 = 34.09 nM | SANGER | ||
| RS4-11 | Growth inhibition assay | IC50 = 34.86 nM | SANGER | ||
| A3-KAW | Growth inhibition assay | IC50 = 34.96 nM | SANGER | ||
| NCI-H719 | Growth inhibition assay | IC50 = 35.12 nM | SANGER | ||
| GI-1 | Growth inhibition assay | IC50 = 35.16 nM | SANGER | ||
| HEL | Growth inhibition assay | IC50 = 35.8 nM | SANGER | ||
| TE-8 | Growth inhibition assay | IC50 = 35.86 nM | SANGER | ||
| HT-29 | Growth inhibition assay | IC50 = 36.02 nM | SANGER | ||
| SW1783 | Growth inhibition assay | IC50 = 38.58 nM | SANGER | ||
| CGTH-W-1 | Growth inhibition assay | IC50 = 38.74 nM | SANGER | ||
| MEL-HO | Growth inhibition assay | IC50 = 39.4 nM | SANGER | ||
| SW620 | Growth inhibition assay | IC50 = 39.79 nM | SANGER | ||
| ME-180 | Growth inhibition assay | IC50 = 40.11 nM | SANGER | ||
| CAL-27 | Growth inhibition assay | IC50 = 41.18 nM | SANGER | ||
| A431 | Growth inhibition assay | IC50 = 43.77 nM | SANGER | ||
| SW954 | Growth inhibition assay | IC50 = 44.91 nM | SANGER | ||
| CAL-39 | Growth inhibition assay | IC50 = 46.49 nM | SANGER | ||
| LU-134-A | Growth inhibition assay | IC50 = 46.72 nM | SANGER | ||
| DU-4475 | Growth inhibition assay | IC50 = 47.47 nM | SANGER | ||
| DEL | Growth inhibition assay | IC50 = 48.39 nM | SANGER | ||
| HGC-27 | Growth inhibition assay | IC50 = 49.29 nM | SANGER | ||
| RH-1 | Growth inhibition assay | IC50 = 49.57 nM | SANGER | ||
| SK-MES-1 | Growth inhibition assay | IC50 = 51.12 nM | SANGER | ||
| MEL-JUSO | Growth inhibition assay | IC50 = 51.25 nM | SANGER | ||
| VA-ES-BJ | Growth inhibition assay | IC50 = 52.16 nM | SANGER | ||
| EW-13 | Growth inhibition assay | IC50 = 52.51 nM | SANGER | ||
| Ca-Ski | Growth inhibition assay | IC50 = 53.75 nM | SANGER | ||
| LXF-289 | Growth inhibition assay | IC50 = 55.37 nM | SANGER | ||
| IM-9 | Growth inhibition assay | IC50 = 56.22 nM | SANGER | ||
| HCE-4 | Growth inhibition assay | IC50 = 57.94 nM | SANGER | ||
| TYK-nu | Growth inhibition assay | IC50 = 58.73 nM | SANGER | ||
| NCI-H748 | Growth inhibition assay | IC50 = 59.54 nM | SANGER | ||
| ABC-1 | Growth inhibition assay | IC50 = 61.2 nM | SANGER | ||
| CCRF-CEM | Growth inhibition assay | IC50 = 61.68 nM | SANGER | ||
| EW-3 | Growth inhibition assay | IC50 = 61.95 nM | SANGER | ||
| NCI-H2342 | Growth inhibition assay | IC50 = 62.51 nM | SANGER | ||
| SK-PN-DW | Growth inhibition assay | IC50 = 63.76 nM | SANGER | ||
| EB2 | Growth inhibition assay | IC50 = 65.36 nM | SANGER | ||
| CAL-85-1 | Growth inhibition assay | IC50 = 65.88 nM | SANGER | ||
| NCI-H526 | Growth inhibition assay | IC50 = 67.37 nM | SANGER | ||
| MFH-ino | Growth inhibition assay | IC50 = 70.61 nM | SANGER | ||
| ACHN | Growth inhibition assay | IC50 = 72.08 nM | SANGER | ||
| MONO-MAC-6 | Growth inhibition assay | IC50 = 72.35 nM | SANGER | ||
| CHP-126 | Growth inhibition assay | IC50 = 72.44 nM | SANGER | ||
| SW1710 | Growth inhibition assay | IC50 = 72.58 nM | SANGER | ||
| TE-10 | Growth inhibition assay | IC50 = 72.6 nM | SANGER | ||
| TE-15 | Growth inhibition assay | IC50 = 73.7 nM | SANGER | ||
| PANC-10-05 | Growth inhibition assay | IC50 = 73.75 nM | SANGER | ||
| BHY | Growth inhibition assay | IC50 = 75.28 nM | SANGER | ||
| HSC-3 | Growth inhibition assay | IC50 = 75.54 nM | SANGER | ||
| COLO-800 | Growth inhibition assay | IC50 = 78.66 nM | SANGER | ||
| NB10 | Growth inhibition assay | IC50 = 81.65 nM | SANGER | ||
| SK-UT-1 | Growth inhibition assay | IC50 = 82.8 nM | SANGER | ||
| HSC-2 | Growth inhibition assay | IC50 = 83.42 nM | SANGER | ||
| GP5d | Growth inhibition assay | IC50 = 84 nM | SANGER | ||
| A204 | Growth inhibition assay | IC50 = 84.19 nM | SANGER | ||
| BFTC-909 | Growth inhibition assay | IC50 = 85.27 nM | SANGER | ||
| NCI-H2087 | Growth inhibition assay | IC50 = 85.69 nM | SANGER | ||
| G-402 | Growth inhibition assay | IC50 = 85.92 nM | SANGER | ||
| 647-V | Growth inhibition assay | IC50 = 87.39 nM | SANGER | ||
| Daoy | Growth inhibition assay | IC50 = 88.01 nM | SANGER | ||
| EW-1 | Growth inhibition assay | IC50 = 88.07 nM | SANGER | ||
| BC-1 | Growth inhibition assay | IC50 = 88.81 nM | SANGER | ||
| OAW-42 | Growth inhibition assay | IC50 = 89.42 nM | SANGER | ||
| COLO-679 | Growth inhibition assay | IC50 = 90.25 nM | SANGER | ||
| TE-11 | Growth inhibition assay | IC50 = 91.77 nM | SANGER | ||
| BFTC-905 | Growth inhibition assay | IC50 = 92.69 nM | SANGER | ||
| KP-4 | Growth inhibition assay | IC50 = 93.15 nM | SANGER | ||
| DOHH-2 | Growth inhibition assay | IC50 = 93.83 nM | SANGER | ||
| L-540 | Growth inhibition assay | IC50 = 95.14 nM | SANGER | ||
| DSH1 | Growth inhibition assay | IC50 = 96.53 nM | SANGER | ||
| M059J | Growth inhibition assay | IC50 = 100.6 nM | SANGER | ||
| UM-UC-3 | Growth inhibition assay | IC50 = 101.83 nM | SANGER | ||
| ES5 | Growth inhibition assay | IC50 = 102.42 nM | SANGER | ||
| KYSE-270 | Growth inhibition assay | IC50 = 102.84 nM | SANGER | ||
| OCUB-M | Growth inhibition assay | IC50 = 102.98 nM | SANGER | ||
| C-4-II | Growth inhibition assay | IC50 = 103.51 nM | SANGER | ||
| BOKU | Growth inhibition assay | IC50 = 103.78 nM | SANGER | ||
| 8-MG-BA | Growth inhibition assay | IC50 = 104 nM | SANGER | ||
| SW982 | Growth inhibition assay | IC50 = 104.73 nM | SANGER | ||
| AGS | Growth inhibition assay | IC50 = 105.8 nM | SANGER | ||
| IGROV-1 | Growth inhibition assay | IC50 = 105.97 nM | SANGER | ||
| HL-60 | Growth inhibition assay | IC50 = 106.06 nM | SANGER | ||
| A2780 | Growth inhibition assay | IC50 = 106.63 nM | SANGER | ||
| HOS | Growth inhibition assay | IC50 = 106.7 nM | SANGER | ||
| HuP-T4 | Growth inhibition assay | IC50 = 108.1 nM | SANGER | ||
| ETK-1 | Growth inhibition assay | IC50 = 108.24 nM | SANGER | ||
| IA-LM | Growth inhibition assay | IC50 = 108.63 nM | SANGER | ||
| MRK-nu-1 | Growth inhibition assay | IC50 = 110.25 nM | SANGER | ||
| SUP-T1 | Growth inhibition assay | IC50 = 110.4 nM | SANGER | ||
| A2058 | Growth inhibition assay | IC50 = 115.1 nM | SANGER | ||
| CAPAN-1 | Growth inhibition assay | IC50 = 116.4 nM | SANGER | ||
| NCI-H1355 | Growth inhibition assay | IC50 = 116.8 nM | SANGER | ||
| NCI-H1618 | Growth inhibition assay | IC50 = 117.76 nM | SANGER | ||
| QIMR-WIL | Growth inhibition assay | IC50 = 119.58 nM | SANGER | ||
| HCC1599 | Growth inhibition assay | IC50 = 120.17 nM | SANGER | ||
| GR-ST | Growth inhibition assay | IC50 = 121.34 nM | SANGER | ||
| G-361 | Growth inhibition assay | IC50 = 123.93 nM | SANGER | ||
| RKO | Growth inhibition assay | IC50 = 125.29 nM | SANGER | ||
| NCI-H1437 | Growth inhibition assay | IC50 = 126.26 nM | SANGER | ||
| SF539 | Growth inhibition assay | IC50 = 127.02 nM | SANGER | ||
| ACN | Growth inhibition assay | IC50 = 127.91 nM | SANGER | ||
| FADU | Growth inhibition assay | IC50 = 128.29 nM | SANGER | ||
| U251 | Growth inhibition assay | IC50 = 128.73 nM | SANGER | ||
| KALS-1 | Growth inhibition assay | IC50 = 129.14 nM | SANGER | ||
| KM-H2 | Growth inhibition assay | IC50 = 130.45 nM | SANGER | ||
| SJSA-1 | Growth inhibition assay | IC50 = 131.56 nM | SANGER | ||
| TE-5 | Growth inhibition assay | IC50 = 132.24 nM | SANGER | ||
| SNG-M | Growth inhibition assay | IC50 = 134.17 nM | SANGER | ||
| HCC1806 | Growth inhibition assay | IC50 = 134.54 nM | SANGER | ||
| NCI-H1734 | Growth inhibition assay | IC50 = 136.85 nM | SANGER | ||
| LCLC-97TM1 | Growth inhibition assay | IC50 = 138.72 nM | SANGER | ||
| NH-12 | Growth inhibition assay | IC50 = 139.13 nM | SANGER | ||
| A375 | Growth inhibition assay | IC50 = 139.42 nM | SANGER | ||
| NCI-SNU-5 | Growth inhibition assay | IC50 = 141.21 nM | SANGER | ||
| SK-OV-3 | Growth inhibition assay | IC50 = 142.64 nM | SANGER | ||
| 22RV1 | Growth inhibition assay | IC50 = 144.07 nM | SANGER | ||
| SW1573 | Growth inhibition assay | IC50 = 144.68 nM | SANGER | ||
| BB65-RCC | Growth inhibition assay | IC50 = 144.71 nM | SANGER | ||
| MES-SA | Growth inhibition assay | IC50 = 144.94 nM | SANGER | ||
| K052 | Growth inhibition assay | IC50 = 149.34 nM | SANGER | ||
| KU812 | Growth inhibition assay | IC50 = 149.96 nM | SANGER | ||
| NOMO-1 | Growth inhibition assay | IC50 = 151.41 nM | SANGER | ||
| Ca9-22 | Growth inhibition assay | IC50 = 155.57 nM | SANGER | ||
| 8305C | Growth inhibition assay | IC50 = 155.75 nM | SANGER | ||
| NCI-SNU-1 | Growth inhibition assay | IC50 = 156.24 nM | SANGER | ||
| HC-1 | Growth inhibition assay | IC50 = 156.51 nM | SANGER | ||
| SW962 | Growth inhibition assay | IC50 = 157.55 nM | SANGER | ||
| HCC2998 | Growth inhibition assay | IC50 = 160.13 nM | SANGER | ||
| DMS-273 | Growth inhibition assay | IC50 = 160.83 nM | SANGER | ||
| MC-CAR | Growth inhibition assay | IC50 = 160.91 nM | SANGER | ||
| Caov-3 | Growth inhibition assay | IC50 = 161.72 nM | SANGER | ||
| EoL-1-cell | Growth inhibition assay | IC50 = 162.39 nM | SANGER | ||
| MKN45 | Growth inhibition assay | IC50 = 165.04 nM | SANGER | ||
| TE-1 | Growth inhibition assay | IC50 = 165.38 nM | SANGER | ||
| HMV-II | Growth inhibition assay | IC50 = 166.06 nM | SANGER | ||
| SK-NEP-1 | Growth inhibition assay | IC50 = 166.53 nM | SANGER | ||
| PANC-03-27 | Growth inhibition assay | IC50 = 167.16 nM | SANGER | ||
| RPMI-7951 | Growth inhibition assay | IC50 = 167.55 nM | SANGER | ||
| NCI-H520 | Growth inhibition assay | IC50 = 168.65 nM | SANGER | ||
| NCI-H522 | Growth inhibition assay | IC50 = 169.45 nM | SANGER | ||
| Detroit562 | Growth inhibition assay | IC50 = 170.26 nM | SANGER | ||
| SF268 | Growth inhibition assay | IC50 = 170.86 nM | SANGER | ||
| T84 | Growth inhibition assay | IC50 = 173.34 nM | SANGER | ||
| NB69 | Growth inhibition assay | IC50 = 175.06 nM | SANGER | ||
| OVCAR-8 | Growth inhibition assay | IC50 = 175.54 nM | SANGER | ||
| RT-112 | Growth inhibition assay | IC50 = 177.98 nM | SANGER | ||
| DoTc2-4510 | Growth inhibition assay | IC50 = 180.37 nM | SANGER | ||
| J-RT3-T3-5 | Growth inhibition assay | IC50 = 185.8 nM | SANGER | ||
| NB1 | Growth inhibition assay | IC50 = 186.61 nM | SANGER | ||
| NEC8 | Growth inhibition assay | IC50 = 186.77 nM | SANGER | ||
| TUR | Growth inhibition assay | IC50 = 189.67 nM | SANGER | ||
| TE-12 | Growth inhibition assay | IC50 = 189.83 nM | SANGER | ||
| WSU-NHL | Growth inhibition assay | IC50 = 192.04 nM | SANGER | ||
| MHH-NB-11 | Growth inhibition assay | IC50 = 192.55 nM | SANGER | ||
| SW48 | Growth inhibition assay | IC50 = 193.36 nM | SANGER | ||
| C3A | Growth inhibition assay | IC50 = 194.31 nM | SANGER | ||
| RPMI-2650 | Growth inhibition assay | IC50 = 195.75 nM | SANGER | ||
| VMRC-RCZ | Growth inhibition assay | IC50 = 198.77 nM | SANGER | ||
| SK-CO-1 | Growth inhibition assay | IC50 = 0.20181 μM | SANGER | ||
| KYSE-180 | Growth inhibition assay | IC50 = 0.20219 μM | SANGER | ||
| KGN | Growth inhibition assay | IC50 = 0.20713 μM | SANGER | ||
| A388 | Growth inhibition assay | IC50 = 0.20722 μM | SANGER | ||
| NCI-H2030 | Growth inhibition assay | IC50 = 0.21132 μM | SANGER | ||
| NCI-H727 | Growth inhibition assay | IC50 = 0.2118 μM | SANGER | ||
| BC-3 | Growth inhibition assay | IC50 = 0.21208 μM | SANGER | ||
| CCF-STTG1 | Growth inhibition assay | IC50 = 0.21559 μM | SANGER | ||
| NMC-G1 | Growth inhibition assay | IC50 = 0.21675 μM | SANGER | ||
| NCI-H1299 | Growth inhibition assay | IC50 = 0.21841 μM | SANGER | ||
| RPMI-6666 | Growth inhibition assay | IC50 = 0.21961 μM | SANGER | ||
| D-283MED | Growth inhibition assay | IC50 = 0.22069 μM | SANGER | ||
| AM-38 | Growth inhibition assay | IC50 = 0.22116 μM | SANGER | ||
| LU-99A | Growth inhibition assay | IC50 = 0.22424 μM | SANGER | ||
| KYSE-70 | Growth inhibition assay | IC50 = 0.22431 μM | SANGER | ||
| CHL-1 | Growth inhibition assay | IC50 = 0.22516 μM | SANGER | ||
| CESS | Growth inhibition assay | IC50 = 0.2254 μM | SANGER | ||
| A4-Fuk | Growth inhibition assay | IC50 = 0.22543 μM | SANGER | ||
| MG-63 | Growth inhibition assay | IC50 = 0.22618 μM | SANGER | ||
| MKN28 | Growth inhibition assay | IC50 = 0.23009 μM | SANGER | ||
| NCI-H1417 | Growth inhibition assay | IC50 = 0.2369 μM | SANGER | ||
| BCPAP | Growth inhibition assay | IC50 = 0.2396 μM | SANGER | ||
| COR-L23 | Growth inhibition assay | IC50 = 0.24094 μM | SANGER | ||
| SIMA | Growth inhibition assay | IC50 = 0.24142 μM | SANGER | ||
| CAL-62 | Growth inhibition assay | IC50 = 0.24185 μM | SANGER | ||
| ARH-77 | Growth inhibition assay | IC50 = 0.24331 μM | SANGER | ||
| COLO-680N | Growth inhibition assay | IC50 = 0.2441 μM | SANGER | ||
| T-24 | Growth inhibition assay | IC50 = 0.24577 μM | SANGER | ||
| PF-382 | Growth inhibition assay | IC50 = 0.25063 μM | SANGER | ||
| NCI-H810 | Growth inhibition assay | IC50 = 0.25161 μM | SANGER | ||
| NCI-H1882 | Growth inhibition assay | IC50 = 0.25709 μM | SANGER | ||
| A101D | Growth inhibition assay | IC50 = 0.25745 μM | SANGER | ||
| NCI-H2126 | Growth inhibition assay | IC50 = 0.2602 μM | SANGER | ||
| VM-CUB-1 | Growth inhibition assay | IC50 = 0.26082 μM | SANGER | ||
| OS-RC-2 | Growth inhibition assay | IC50 = 0.2637 μM | SANGER | ||
| MIA-PaCa-2 | Growth inhibition assay | IC50 = 0.27545 μM | SANGER | ||
| SW837 | Growth inhibition assay | IC50 = 0.27613 μM | SANGER | ||
| NCI-H358 | Growth inhibition assay | IC50 = 0.27626 μM | SANGER | ||
| NCI-H1703 | Growth inhibition assay | IC50 = 0.27688 μM | SANGER | ||
| NCI-H1650 | Growth inhibition assay | IC50 = 0.28257 μM | SANGER | ||
| SW626 | Growth inhibition assay | IC50 = 0.28622 μM | SANGER | ||
| MFE-296 | Growth inhibition assay | IC50 = 0.28623 μM | SANGER | ||
| NCI-H2009 | Growth inhibition assay | IC50 = 0.28857 μM | SANGER | ||
| NCI-H2405 | Growth inhibition assay | IC50 = 0.29434 μM | SANGER | ||
| BL-41 | Growth inhibition assay | IC50 = 0.2949 μM | SANGER | ||
| SNU-C2B | Growth inhibition assay | IC50 = 0.29505 μM | SANGER | ||
| no-10 | Growth inhibition assay | IC50 = 0.2996 μM | SANGER | ||
| A427 | Growth inhibition assay | IC50 = 0.30133 μM | SANGER | ||
| SNB75 | Growth inhibition assay | IC50 = 0.30346 μM | SANGER | ||
| CTB-1 | Growth inhibition assay | IC50 = 0.30637 μM | SANGER | ||
| BT-20 | Growth inhibition assay | IC50 = 0.31197 μM | SANGER | ||
| GT3TKB | Growth inhibition assay | IC50 = 0.31823 μM | SANGER | ||
| COR-L88 | Growth inhibition assay | IC50 = 0.31914 μM | SANGER | ||
| Calu-6 | Growth inhibition assay | IC50 = 0.31971 μM | SANGER | ||
| Calu-3 | Growth inhibition assay | IC50 = 0.32095 μM | SANGER | ||
| IGR-1 | Growth inhibition assay | IC50 = 0.3216 μM | SANGER | ||
| LS-411N | Growth inhibition assay | IC50 = 0.32176 μM | SANGER | ||
| LAN-6 | Growth inhibition assay | IC50 = 0.32779 μM | SANGER | ||
| ONS-76 | Growth inhibition assay | IC50 = 0.32956 μM | SANGER | ||
| MZ7-mel | Growth inhibition assay | IC50 = 0.33256 μM | SANGER | ||
| LB647-SCLC | Growth inhibition assay | IC50 = 0.33608 μM | SANGER | ||
| OE33 | Growth inhibition assay | IC50 = 0.3378 μM | SANGER | ||
| NCI-H1770 | Growth inhibition assay | IC50 = 0.34265 μM | SANGER | ||
| MS-1 | Growth inhibition assay | IC50 = 0.34402 μM | SANGER | ||
| NCI-H650 | Growth inhibition assay | IC50 = 0.34407 μM | SANGER | ||
| MDA-MB-468 | Growth inhibition assay | IC50 = 0.34531 μM | SANGER | ||
| A253 | Growth inhibition assay | IC50 = 0.34564 μM | SANGER | ||
| LOXIMVI | Growth inhibition assay | IC50 = 0.3525 μM | SANGER | ||
| BB49-HNC | Growth inhibition assay | IC50 = 0.35252 μM | SANGER | ||
| HT-1080 | Growth inhibition assay | IC50 = 0.35371 μM | SANGER | ||
| NB5 | Growth inhibition assay | IC50 = 0.3579 μM | SANGER | ||
| LK-2 | Growth inhibition assay | IC50 = 0.35814 μM | SANGER | ||
| KS-1 | Growth inhibition assay | IC50 = 0.36415 μM | SANGER | ||
| OE19 | Growth inhibition assay | IC50 = 0.36496 μM | SANGER | ||
| U031 | Growth inhibition assay | IC50 = 0.3658 μM | SANGER | ||
| HCE-T | Growth inhibition assay | IC50 = 0.37153 μM | SANGER | ||
| NCI-H1304 | Growth inhibition assay | IC50 = 0.37523 μM | SANGER | ||
| SKG-IIIa | Growth inhibition assay | IC50 = 0.37738 μM | SANGER | ||
| GDM-1 | Growth inhibition assay | IC50 = 0.37746 μM | SANGER | ||
| CPC-N | Growth inhibition assay | IC50 = 0.38066 μM | SANGER | ||
| KYSE-140 | Growth inhibition assay | IC50 = 0.38134 μM | SANGER | ||
| SH-4 | Growth inhibition assay | IC50 = 0.38726 μM | SANGER | ||
| IST-SL2 | Growth inhibition assay | IC50 = 0.38762 μM | SANGER | ||
| SCC-4 | Growth inhibition assay | IC50 = 0.3877 μM | SANGER | ||
| OMC-1 | Growth inhibition assay | IC50 = 0.38955 μM | SANGER | ||
| Daudi | Growth inhibition assay | IC50 = 0.39242 μM | SANGER | ||
| JVM-2 | Growth inhibition assay | IC50 = 0.39734 μM | SANGER | ||
| NCI-H510A | Growth inhibition assay | IC50 = 0.40282 μM | SANGER | ||
| NCI-H1838 | Growth inhibition assay | IC50 = 0.40419 μM | SANGER | ||
| GCIY | Growth inhibition assay | IC50 = 0.41099 μM | SANGER | ||
| NCI-H747 | Growth inhibition assay | IC50 = 0.41159 μM | SANGER | ||
| NCI-H1694 | Growth inhibition assay | IC50 = 0.41528 μM | SANGER | ||
| UACC-893 | Growth inhibition assay | IC50 = 0.41801 μM | SANGER | ||
| DMS-153 | Growth inhibition assay | IC50 = 0.42526 μM | SANGER | ||
| GAMG | Growth inhibition assay | IC50 = 0.42821 μM | SANGER | ||
| LB373-MEL-D | Growth inhibition assay | IC50 = 0.42962 μM | SANGER | ||
| 8505C | Growth inhibition assay | IC50 = 0.42983 μM | SANGER | ||
| DB | Growth inhibition assay | IC50 = 0.42995 μM | SANGER | ||
| LoVo | Growth inhibition assay | IC50 = 0.43068 μM | SANGER | ||
| MZ2-MEL | Growth inhibition assay | IC50 = 0.43247 μM | SANGER | ||
| L-363 | Growth inhibition assay | IC50 = 0.43417 μM | SANGER | ||
| HSC-4 | Growth inhibition assay | IC50 = 0.43445 μM | SANGER | ||
| NCI-N87 | Growth inhibition assay | IC50 = 0.43812 μM | SANGER | ||
| SK-LMS-1 | Growth inhibition assay | IC50 = 0.43929 μM | SANGER | ||
| HO-1-N-1 | Growth inhibition assay | IC50 = 0.44064 μM | SANGER | ||
| OAW-28 | Growth inhibition assay | IC50 = 0.44065 μM | SANGER | ||
| SBC-1 | Growth inhibition assay | IC50 = 0.4477 μM | SANGER | ||
| LNCaP-Clone-FGC | Growth inhibition assay | IC50 = 0.45008 μM | SANGER | ||
| MZ1-PC | Growth inhibition assay | IC50 = 0.45011 μM | SANGER | ||
| GB-1 | Growth inhibition assay | IC50 = 0.45218 μM | SANGER | ||
| LCLC-103H | Growth inhibition assay | IC50 = 0.46087 μM | SANGER | ||
| YT | Growth inhibition assay | IC50 = 0.46333 μM | SANGER | ||
| HCT-15 | Growth inhibition assay | IC50 = 0.46462 μM | SANGER | ||
| CaR-1 | Growth inhibition assay | IC50 = 0.46878 μM | SANGER | ||
| SK-MEL-30 | Growth inhibition assay | IC50 = 0.47431 μM | SANGER | ||
| TCCSUP | Growth inhibition assay | IC50 = 0.4817 μM | SANGER | ||
| C-33-A | Growth inhibition assay | IC50 = 0.48687 μM | SANGER | ||
| OVCAR-5 | Growth inhibition assay | IC50 = 0.48711 μM | SANGER | ||
| CAL-12T | Growth inhibition assay | IC50 = 0.49125 μM | SANGER | ||
| PC-14 | Growth inhibition assay | IC50 = 0.49127 μM | SANGER | ||
| ST486 | Growth inhibition assay | IC50 = 0.49436 μM | SANGER | ||
| HLE | Growth inhibition assay | IC50 = 0.49832 μM | SANGER | ||
| TE-9 | Growth inhibition assay | IC50 = 0.50049 μM | SANGER | ||
| AU565 | Growth inhibition assay | IC50 = 0.50096 μM | SANGER | ||
| LU-165 | Growth inhibition assay | IC50 = 0.51311 μM | SANGER | ||
| EW-11 | Growth inhibition assay | IC50 = 0.51336 μM | SANGER | ||
| FTC-133 | Growth inhibition assay | IC50 = 0.51722 μM | SANGER | ||
| NCI-H1648 | Growth inhibition assay | IC50 = 0.52301 μM | SANGER | ||
| AN3-CA | Growth inhibition assay | IC50 = 0.52328 μM | SANGER | ||
| KURAMOCHI | Growth inhibition assay | IC50 = 0.52344 μM | SANGER | ||
| T98G | Growth inhibition assay | IC50 = 0.52375 μM | SANGER | ||
| TK10 | Growth inhibition assay | IC50 = 0.52832 μM | SANGER | ||
| LB2518-MEL | Growth inhibition assay | IC50 = 0.53456 μM | SANGER | ||
| CAL-33 | Growth inhibition assay | IC50 = 0.53653 μM | SANGER | ||
| A172 | Growth inhibition assay | IC50 = 0.53752 μM | SANGER | ||
| D-263MG | Growth inhibition assay | IC50 = 0.54004 μM | SANGER | ||
| CAMA-1 | Growth inhibition assay | IC50 = 0.54059 μM | SANGER | ||
| MKN1 | Growth inhibition assay | IC50 = 0.54081 μM | SANGER | ||
| NCI-H661 | Growth inhibition assay | IC50 = 0.54158 μM | SANGER | ||
| YKG-1 | Growth inhibition assay | IC50 = 0.545 μM | SANGER | ||
| GOTO | Growth inhibition assay | IC50 = 0.55371 μM | SANGER | ||
| KYSE-450 | Growth inhibition assay | IC50 = 0.56311 μM | SANGER | ||
| UMC-11 | Growth inhibition assay | IC50 = 0.56701 μM | SANGER | ||
| DBTRG-05MG | Growth inhibition assay | IC50 = 0.57026 μM | SANGER | ||
| KYSE-410 | Growth inhibition assay | IC50 = 0.58359 μM | SANGER | ||
| MOLT-16 | Growth inhibition assay | IC50 = 0.58519 μM | SANGER | ||
| HCC2218 | Growth inhibition assay | IC50 = 0.58882 μM | SANGER | ||
| EFO-21 | Growth inhibition assay | IC50 = 0.59114 μM | SANGER | ||
| S-117 | Growth inhibition assay | IC50 = 0.59244 μM | SANGER | ||
| HCC1937 | Growth inhibition assay | IC50 = 0.59382 μM | SANGER | ||
| THP-1 | Growth inhibition assay | IC50 = 0.5955 μM | SANGER | ||
| GAK | Growth inhibition assay | IC50 = 0.59624 μM | SANGER | ||
| SW756 | Growth inhibition assay | IC50 = 0.59691 μM | SANGER | ||
| KG-1 | Growth inhibition assay | IC50 = 0.59714 μM | SANGER | ||
| D-542MG | Growth inhibition assay | IC50 = 0.60165 μM | SANGER | ||
| HCC38 | Growth inhibition assay | IC50 = 0.60411 μM | SANGER | ||
| SAS | Growth inhibition assay | IC50 = 0.61465 μM | SANGER | ||
| RVH-421 | Growth inhibition assay | IC50 = 0.62917 μM | SANGER | ||
| JiyoyeP-2003 | Growth inhibition assay | IC50 = 0.62954 μM | SANGER | ||
| G-401 | Growth inhibition assay | IC50 = 0.63447 μM | SANGER | ||
| SW1990 | Growth inhibition assay | IC50 = 0.63705 μM | SANGER | ||
| KP-N-YS | Growth inhibition assay | IC50 = 0.64012 μM | SANGER | ||
| HD-MY-Z | Growth inhibition assay | IC50 = 0.64025 μM | SANGER | ||
| LAMA-84 | Growth inhibition assay | IC50 = 0.64166 μM | SANGER | ||
| SW13 | Growth inhibition assay | IC50 = 0.64249 μM | SANGER | ||
| HCC1569 | Growth inhibition assay | IC50 = 0.64461 μM | SANGER | ||
| CP66-MEL | Growth inhibition assay | IC50 = 0.64495 μM | SANGER | ||
| SK-HEP-1 | Growth inhibition assay | IC50 = 0.64566 μM | SANGER | ||
| NB13 | Growth inhibition assay | IC50 = 0.64603 μM | SANGER | ||
| NY | Growth inhibition assay | IC50 = 0.65739 μM | SANGER | ||
| EHEB | Growth inhibition assay | IC50 = 0.67213 μM | SANGER | ||
| MEG-01 | Growth inhibition assay | IC50 = 0.68336 μM | SANGER | ||
| HCC70 | Growth inhibition assay | IC50 = 0.69433 μM | SANGER | ||
| OVCAR-4 | Growth inhibition assay | IC50 = 0.69691 μM | SANGER | ||
| NCI-H1792 | Growth inhibition assay | IC50 = 0.69734 μM | SANGER | ||
| HEC-1 | Growth inhibition assay | IC50 = 0.69824 μM | SANGER | ||
| NCI-H187 | Growth inhibition assay | IC50 = 0.70799 μM | SANGER | ||
| TGBC24TKB | Growth inhibition assay | IC50 = 0.71 μM | SANGER | ||
| HuP-T3 | Growth inhibition assay | IC50 = 0.71055 μM | SANGER | ||
| SK-MEL-3 | Growth inhibition assay | IC50 = 0.71112 μM | SANGER | ||
| MDA-MB-415 | Growth inhibition assay | IC50 = 0.72395 μM | SANGER | ||
| HCC2157 | Growth inhibition assay | IC50 = 0.72685 μM | SANGER | ||
| NCI-H2081 | Growth inhibition assay | IC50 = 0.74057 μM | SANGER | ||
| ES6 | Growth inhibition assay | IC50 = 0.74562 μM | SANGER | ||
| KYSE-520 | Growth inhibition assay | IC50 = 0.77218 μM | SANGER | ||
| BxPC-3 | Growth inhibition assay | IC50 = 0.77478 μM | SANGER | ||
| NCI-H226 | Growth inhibition assay | IC50 = 0.77721 μM | SANGER | ||
| LB771-HNC | Growth inhibition assay | IC50 = 0.77974 μM | SANGER | ||
| CP50-MEL-B | Growth inhibition assay | IC50 = 0.78003 μM | SANGER | ||
| HN | Growth inhibition assay | IC50 = 0.78254 μM | SANGER | ||
| EW-24 | Growth inhibition assay | IC50 = 0.78297 μM | SANGER | ||
| A673 | Growth inhibition assay | IC50 = 0.7896 μM | SANGER | ||
| COLO-684 | Growth inhibition assay | IC50 = 0.7993 μM | SANGER | ||
| DMS-53 | Growth inhibition assay | IC50 = 0.80856 μM | SANGER | ||
| MDA-MB-361 | Growth inhibition assay | IC50 = 0.80898 μM | SANGER | ||
| SNU-475 | Growth inhibition assay | IC50 = 0.81314 μM | SANGER | ||
| LB831-BLC | Growth inhibition assay | IC50 = 0.81608 μM | SANGER | ||
| RCM-1 | Growth inhibition assay | IC50 = 0.84728 μM | SANGER | ||
| NCI-H2347 | Growth inhibition assay | IC50 = 0.84997 μM | SANGER | ||
| NCI-H2141 | Growth inhibition assay | IC50 = 0.85281 μM | SANGER | ||
| Becker | Growth inhibition assay | IC50 = 0.86232 μM | SANGER | ||
| LC-1F | Growth inhibition assay | IC50 = 0.86233 μM | SANGER | ||
| SCC-15 | Growth inhibition assay | IC50 = 0.86386 μM | SANGER | ||
| U-266 | Growth inhibition assay | IC50 = 0.86618 μM | SANGER | ||
| SCC-25 | Growth inhibition assay | IC50 = 0.87036 μM | SANGER | ||
| NCI-H1155 | Growth inhibition assay | IC50 = 0.87336 μM | SANGER | ||
| NCI-H292 | Growth inhibition assay | IC50 = 0.88441 μM | SANGER | ||
| NCI-H2196 | Growth inhibition assay | IC50 = 0.886 μM | SANGER | ||
| EKVX | Growth inhibition assay | IC50 = 0.893 μM | SANGER | ||
| TE-6 | Growth inhibition assay | IC50 = 0.89367 μM | SANGER | ||
| NCI-H1693 | Growth inhibition assay | IC50 = 0.89963 μM | SANGER | ||
| HuCCT1 | Growth inhibition assay | IC50 = 0.90351 μM | SANGER | ||
| NCI-H1581 | Growth inhibition assay | IC50 = 0.90674 μM | SANGER | ||
| KARPAS-422 | Growth inhibition assay | IC50 = 0.90739 μM | SANGER | ||
| C8166 | Growth inhibition assay | IC50 = 0.93232 μM | SANGER | ||
| BEN | Growth inhibition assay | IC50 = 0.93516 μM | SANGER | ||
| SCLC-21H | Growth inhibition assay | IC50 = 0.96303 μM | SANGER | ||
| HT-1376 | Growth inhibition assay | IC50 = 0.96711 μM | SANGER | ||
| NCI-H1963 | Growth inhibition assay | IC50 = 0.97437 μM | SANGER | ||
| MPP-89 | Growth inhibition assay | IC50 = 0.99122 μM | SANGER | ||
| SW1417 | Growth inhibition assay | IC50 = 1.00545 μM | SANGER | ||
| NCCIT | Growth inhibition assay | IC50 = 1.01024 μM | SANGER | ||
| MMAC-SF | Growth inhibition assay | IC50 = 1.01163 μM | SANGER | ||
| LU-65 | Growth inhibition assay | IC50 = 1.01247 μM | SANGER | ||
| NCI-H1623 | Growth inhibition assay | IC50 = 1.01428 μM | SANGER | ||
| HCT-116 | Growth inhibition assay | IC50 = 1.01502 μM | SANGER | ||
| CA46 | Growth inhibition assay | IC50 = 1.0198 μM | SANGER | ||
| RERF-LC-MS | Growth inhibition assay | IC50 = 1.03157 μM | SANGER | ||
| DJM-1 | Growth inhibition assay | IC50 = 1.03304 μM | SANGER | ||
| EM-2 | Growth inhibition assay | IC50 = 1.03374 μM | SANGER | ||
| HCC1395 | Growth inhibition assay | IC50 = 1.05754 μM | SANGER | ||
| HCC1143 | Growth inhibition assay | IC50 = 1.0664 μM | SANGER | ||
| HH | Growth inhibition assay | IC50 = 1.0738 μM | SANGER | ||
| MDA-MB-453 | Growth inhibition assay | IC50 = 1.07917 μM | SANGER | ||
| COLO-320-HSR | Growth inhibition assay | IC50 = 1.0792 μM | SANGER | ||
| KM12 | Growth inhibition assay | IC50 = 1.08364 μM | SANGER | ||
| KNS-42 | Growth inhibition assay | IC50 = 1.09239 μM | SANGER | ||
| HPAF-II | Growth inhibition assay | IC50 = 1.09715 μM | SANGER | ||
| OVCAR-3 | Growth inhibition assay | IC50 = 1.12787 μM | SANGER | ||
| EFO-27 | Growth inhibition assay | IC50 = 1.13122 μM | SANGER | ||
| L-428 | Growth inhibition assay | IC50 = 1.15778 μM | SANGER | ||
| LS-513 | Growth inhibition assay | IC50 = 1.17808 μM | SANGER | ||
| NB12 | Growth inhibition assay | IC50 = 1.20371 μM | SANGER | ||
| NCI-H23 | Growth inhibition assay | IC50 = 1.20661 μM | SANGER | ||
| TGBC1TKB | Growth inhibition assay | IC50 = 1.21141 μM | SANGER | ||
| LU-139 | Growth inhibition assay | IC50 = 1.21841 μM | SANGER | ||
| Raji | Growth inhibition assay | IC50 = 1.22094 μM | SANGER | ||
| IPC-298 | Growth inhibition assay | IC50 = 1.22841 μM | SANGER | ||
| NCI-H838 | Growth inhibition assay | IC50 = 1.23291 μM | SANGER | ||
| RPMI-8226 | Growth inhibition assay | IC50 = 1.23847 μM | SANGER | ||
| LC4-1 | Growth inhibition assay | IC50 = 1.23959 μM | SANGER | ||
| MN-60 | Growth inhibition assay | IC50 = 1.26332 μM | SANGER | ||
| U-87-MG | Growth inhibition assay | IC50 = 1.27372 μM | SANGER | ||
| BL-70 | Growth inhibition assay | IC50 = 1.27667 μM | SANGER | ||
| MLMA | Growth inhibition assay | IC50 = 1.30978 μM | SANGER | ||
| RPMI-8866 | Growth inhibition assay | IC50 = 1.31777 μM | SANGER | ||
| M14 | Growth inhibition assay | IC50 = 1.3376 μM | SANGER | ||
| RCC10RGB | Growth inhibition assay | IC50 = 1.34936 μM | SANGER | ||
| SK-MEL-24 | Growth inhibition assay | IC50 = 1.37423 μM | SANGER | ||
| SHP-77 | Growth inhibition assay | IC50 = 1.3783 μM | SANGER | ||
| EFE-184 | Growth inhibition assay | IC50 = 1.38125 μM | SANGER | ||
| GI-ME-N | Growth inhibition assay | IC50 = 1.39089 μM | SANGER | ||
| SF126 | Growth inhibition assay | IC50 = 1.40565 μM | SANGER | ||
| Saos-2 | Growth inhibition assay | IC50 = 1.40649 μM | SANGER | ||
| KARPAS-299 | Growth inhibition assay | IC50 = 1.41651 μM | SANGER | ||
| MC116 | Growth inhibition assay | IC50 = 1.41664 μM | SANGER | ||
| NCI-H1563 | Growth inhibition assay | IC50 = 1.42784 μM | SANGER | ||
| COLO-824 | Growth inhibition assay | IC50 = 1.44461 μM | SANGER | ||
| IST-SL1 | Growth inhibition assay | IC50 = 1.4462 μM | SANGER | ||
| HDLM-2 | Growth inhibition assay | IC50 = 1.4601 μM | SANGER | ||
| NCI-H1573 | Growth inhibition assay | IC50 = 1.46085 μM | SANGER | ||
| NCI-H2171 | Growth inhibition assay | IC50 = 1.49785 μM | SANGER | ||
| NOS-1 | Growth inhibition assay | IC50 = 1.50227 μM | SANGER | ||
| COLO-792 | Growth inhibition assay | IC50 = 1.50264 μM | SANGER | ||
| SNU-423 | Growth inhibition assay | IC50 = 1.52181 μM | SANGER | ||
| C32 | Growth inhibition assay | IC50 = 1.52834 μM | SANGER | ||
| KOSC-2 | Growth inhibition assay | IC50 = 1.53103 μM | SANGER | ||
| NCI-H64 | Growth inhibition assay | IC50 = 1.53444 μM | SANGER | ||
| HT | Growth inhibition assay | IC50 = 1.53659 μM | SANGER | ||
| NCI-H596 | Growth inhibition assay | IC50 = 1.5377 μM | SANGER | ||
| NCI-H720 | Growth inhibition assay | IC50 = 1.54425 μM | SANGER | ||
| UACC-257 | Growth inhibition assay | IC50 = 1.56566 μM | SANGER | ||
| EVSA-T | Growth inhibition assay | IC50 = 1.57368 μM | SANGER | ||
| KNS-81-FD | Growth inhibition assay | IC50 = 1.59446 μM | SANGER | ||
| TE-441-T | Growth inhibition assay | IC50 = 1.60276 μM | SANGER | ||
| U-698-M | Growth inhibition assay | IC50 = 1.60291 μM | SANGER | ||
| COR-L105 | Growth inhibition assay | IC50 = 1.61317 μM | SANGER | ||
| KMOE-2 | Growth inhibition assay | IC50 = 1.62413 μM | SANGER | ||
| KY821 | Growth inhibition assay | IC50 = 1.65078 μM | SANGER | ||
| SJRH30 | Growth inhibition assay | IC50 = 1.6742 μM | SANGER | ||
| NCI-H69 | Growth inhibition assay | IC50 = 1.67882 μM | SANGER | ||
| RT4 | Growth inhibition assay | IC50 = 1.69923 μM | SANGER | ||
| LS-123 | Growth inhibition assay | IC50 = 1.72001 μM | SANGER | ||
| BHT-101 | Growth inhibition assay | IC50 = 1.74029 μM | SANGER | ||
| K5 | Growth inhibition assay | IC50 = 1.78398 μM | SANGER | ||
| SK-N-AS | Growth inhibition assay | IC50 = 1.79073 μM | SANGER | ||
| NCI-H322M | Growth inhibition assay | IC50 = 1.80152 μM | SANGER | ||
| NCI-H1793 | Growth inhibition assay | IC50 = 1.81482 μM | SANGER | ||
| CAL-54 | Growth inhibition assay | IC50 = 1.84148 μM | SANGER | ||
| SK-MEL-1 | Growth inhibition assay | IC50 = 1.88815 μM | SANGER | ||
| SiHa | Growth inhibition assay | IC50 = 1.8934 μM | SANGER | ||
| RD | Growth inhibition assay | IC50 = 1.89846 μM | SANGER | ||
| ChaGo-K-1 | Growth inhibition assay | IC50 = 1.91033 μM | SANGER | ||
| SNU-C1 | Growth inhibition assay | IC50 = 1.914 μM | SANGER | ||
| NCI-H1436 | Growth inhibition assay | IC50 = 1.92742 μM | SANGER | ||
| HOP-92 | Growth inhibition assay | IC50 = 1.93658 μM | SANGER | ||
| HT55 | Growth inhibition assay | IC50 = 1.95457 μM | SANGER | ||
| K-562 | Growth inhibition assay | IC50 = 1.97869 μM | SANGER | ||
| NCI-H2052 | Growth inhibition assay | IC50 = 1.98812 μM | SANGER | ||
| HT-1197 | Growth inhibition assay | IC50 = 2.02174 μM | SANGER | ||
| SW1463 | Growth inhibition assay | IC50 = 2.08169 μM | SANGER | ||
| COLO-829 | Growth inhibition assay | IC50 = 2.08684 μM | SANGER | ||
| DMS-114 | Growth inhibition assay | IC50 = 2.08692 μM | SANGER | ||
| EFM-19 | Growth inhibition assay | IC50 = 2.08896 μM | SANGER | ||
| LN-405 | Growth inhibition assay | IC50 = 2.15428 μM | SANGER | ||
| UACC-62 | Growth inhibition assay | IC50 = 2.15533 μM | SANGER | ||
| MDA-MB-134-VI | Growth inhibition assay | IC50 = 2.1586 μM | SANGER | ||
| MDA-MB-157 | Growth inhibition assay | IC50 = 2.19254 μM | SANGER | ||
| COLO-741 | Growth inhibition assay | IC50 = 2.19928 μM | SANGER | ||
| JEG-3 | Growth inhibition assay | IC50 = 2.23191 μM | SANGER | ||
| NB6 | Growth inhibition assay | IC50 = 2.23352 μM | SANGER | ||
| NCI-H1395 | Growth inhibition assay | IC50 = 2.23483 μM | SANGER | ||
| KARPAS-45 | Growth inhibition assay | IC50 = 2.27184 μM | SANGER | ||
| HCC1954 | Growth inhibition assay | IC50 = 2.28119 μM | SANGER | ||
| A704 | Growth inhibition assay | IC50 = 2.38311 μM | SANGER | ||
| SK-N-DZ | Growth inhibition assay | IC50 = 2.38958 μM | SANGER | ||
| EGI-1 | Growth inhibition assay | IC50 = 2.39059 μM | SANGER | ||
| TALL-1 | Growth inhibition assay | IC50 = 2.3955 μM | SANGER | ||
| PANC-08-13 | Growth inhibition assay | IC50 = 2.39777 μM | SANGER | ||
| NCI-H28 | Growth inhibition assay | IC50 = 2.43524 μM | SANGER | ||
| DMS-79 | Growth inhibition assay | IC50 = 2.47163 μM | SANGER | ||
| NCI-H889 | Growth inhibition assay | IC50 = 2.48342 μM | SANGER | ||
| Ramos-2G6-4C10 | Growth inhibition assay | IC50 = 2.54572 μM | SANGER | ||
| BT-474 | Growth inhibition assay | IC50 = 2.62326 μM | SANGER | ||
| JVM-3 | Growth inhibition assay | IC50 = 2.64752 μM | SANGER | ||
| NCI-H524 | Growth inhibition assay | IC50 = 2.7032 μM | SANGER | ||
| SK-MM-2 | Growth inhibition assay | IC50 = 2.71695 μM | SANGER | ||
| TGW | Growth inhibition assay | IC50 = 2.75803 μM | SANGER | ||
| Capan-2 | Growth inhibition assay | IC50 = 2.78528 μM | SANGER | ||
| NCI-H82 | Growth inhibition assay | IC50 = 2.80193 μM | SANGER | ||
| NCI-H716 | Growth inhibition assay | IC50 = 2.82042 μM | SANGER | ||
| MSTO-211H | Growth inhibition assay | IC50 = 2.82369 μM | SANGER | ||
| COLO-678 | Growth inhibition assay | IC50 = 2.88691 μM | SANGER | ||
| AsPC-1 | Growth inhibition assay | IC50 = 2.89855 μM | SANGER | ||
| DV-90 | Growth inhibition assay | IC50 = 2.92143 μM | SANGER | ||
| SNU-387 | Growth inhibition assay | IC50 = 2.93467 μM | SANGER | ||
| KLE | Growth inhibition assay | IC50 = 2.98224 μM | SANGER | ||
| U-118-MG | Growth inhibition assay | IC50 = 3.14284 μM | SANGER | ||
| MHH-PREB-1 | Growth inhibition assay | IC50 = 3.14735 μM | SANGER | ||
| MDA-MB-175-VII | Growth inhibition assay | IC50 = 3.15819 μM | SANGER | ||
| EB-3 | Growth inhibition assay | IC50 = 3.19768 μM | SANGER | ||
| HuH-7 | Growth inhibition assay | IC50 = 3.22286 μM | SANGER | ||
| NCI-H1522 | Growth inhibition assay | IC50 = 3.23546 μM | SANGER | ||
| MDA-MB-231 | Growth inhibition assay | IC50 = 3.23964 μM | SANGER | ||
| NCI-H1092 | Growth inhibition assay | IC50 = 3.2799 μM | SANGER | ||
| KU-19-19 | Growth inhibition assay | IC50 = 3.35835 μM | SANGER | ||
| SNU-449 | Growth inhibition assay | IC50 = 3.36209 μM | SANGER | ||
| CAS-1 | Growth inhibition assay | IC50 = 3.38185 μM | SANGER | ||
| KP-N-YN | Growth inhibition assay | IC50 = 3.41535 μM | SANGER | ||
| P31-FUJ | Growth inhibition assay | IC50 = 3.45775 μM | SANGER | ||
| RMG-I | Growth inhibition assay | IC50 = 3.46127 μM | SANGER | ||
| SN12C | Growth inhibition assay | IC50 = 3.46177 μM | SANGER | ||
| HCC1419 | Growth inhibition assay | IC50 = 3.48402 μM | SANGER | ||
| TT | Growth inhibition assay | IC50 = 3.67775 μM | SANGER | ||
| SW948 | Growth inhibition assay | IC50 = 3.75281 μM | SANGER | ||
| SCC-9 | Growth inhibition assay | IC50 = 3.78753 μM | SANGER | ||
| KMS-12-PE | Growth inhibition assay | IC50 = 3.82788 μM | SANGER | ||
| GMS-10 | Growth inhibition assay | IC50 = 3.83807 μM | SANGER | ||
| EW-18 | Growth inhibition assay | IC50 = 3.9388 μM | SANGER | ||
| SK-MEL-2 | Growth inhibition assay | IC50 = 3.97464 μM | SANGER | ||
| PC-3 | Growth inhibition assay | IC50 = 4.07159 μM | SANGER | ||
| IST-MES1 | Growth inhibition assay | IC50 = 4.14621 μM | SANGER | ||
| PLC-PRF-5 | Growth inhibition assay | IC50 = 4.19446 μM | SANGER | ||
| YAPC | Growth inhibition assay | IC50 = 4.36751 μM | SANGER | ||
| RXF393 | Growth inhibition assay | IC50 = 4.38975 μM | SANGER | ||
| LP-1 | Growth inhibition assay | IC50 = 4.55967 μM | SANGER | ||
| JAR | Growth inhibition assay | IC50 = 4.56384 μM | SANGER | ||
| GCT | Growth inhibition assay | IC50 = 4.6047 μM | SANGER | ||
| SW1088 | Growth inhibition assay | IC50 = 4.66827 μM | SANGER | ||
| NCI-H345 | Growth inhibition assay | IC50 = 4.73193 μM | SANGER | ||
| Calu-1 | Growth inhibition assay | IC50 = 4.8072 μM | SANGER | ||
| ECC4 | Growth inhibition assay | IC50 = 5.07036 μM | SANGER | ||
| DOK | Growth inhibition assay | IC50 = 5.1551 μM | SANGER | ||
| RL | Growth inhibition assay | IC50 = 5.43657 μM | SANGER | ||
| NCI-H1755 | Growth inhibition assay | IC50 = 5.43694 μM | SANGER | ||
| HTC-C3 | Growth inhibition assay | IC50 = 5.78944 μM | SANGER | ||
| PFSK-1 | Growth inhibition assay | IC50 = 5.88351 μM | SANGER | ||
| CAL-120 | Growth inhibition assay | IC50 = 5.96351 μM | SANGER | ||
| Hs-578-T | Growth inhibition assay | IC50 = 6.20302 μM | SANGER | ||
| DG-75 | Growth inhibition assay | IC50 = 6.2494 μM | SANGER | ||
| NCI-H2227 | Growth inhibition assay | IC50 = 6.32364 μM | SANGER | ||
| OPM-2 | Growth inhibition assay | IC50 = 6.34857 μM | SANGER | ||
| T47D | Growth inhibition assay | IC50 = 6.37191 μM | SANGER | ||
| HuO-3N1 | Growth inhibition assay | IC50 = 6.45452 μM | SANGER | ||
| D-392MG | Growth inhibition assay | IC50 = 6.68451 μM | SANGER | ||
| NCI-SNU-16 | Growth inhibition assay | IC50 = 6.74309 μM | SANGER | ||
| CW-2 | Growth inhibition assay | IC50 = 7.72758 μM | SANGER | ||
| no-11 | Growth inhibition assay | IC50 = 7.74202 μM | SANGER | ||
| MFE-280 | Growth inhibition assay | IC50 = 8.34873 μM | SANGER | ||
| KINGS-1 | Growth inhibition assay | IC50 = 8.61164 μM | SANGER | ||
| HCC1187 | Growth inhibition assay | IC50 = 8.9213 μM | SANGER | ||
| NCI-H2452 | Growth inhibition assay | IC50 = 8.93628 μM | SANGER | ||
| C2BBe1 | Growth inhibition assay | IC50 = 9.284 μM | SANGER | ||
| Mewo | Growth inhibition assay | IC50 = 9.55233 μM | SANGER | ||
| MFM-223 | Growth inhibition assay | IC50 = 10.3807 μM | SANGER | ||
| NCI-H446 | Growth inhibition assay | IC50 = 12.4227 μM | SANGER | ||
| RO82-W-1 | Growth inhibition assay | IC50 = 13.3274 μM | SANGER | ||
| EC-GI-10 | Growth inhibition assay | IC50 = 14.9132 μM | SANGER | ||
| UACC-812 | Growth inhibition assay | IC50 = 16.8306 μM | SANGER | ||
| SK-MEL-28 | Growth inhibition assay | IC50 = 18.9731 μM | SANGER | ||
| DK-MG | Growth inhibition assay | IC50 = 21.667 μM | SANGER | ||
| NCI-H1993 | Growth inhibition assay | IC50 = 22.984 μM | SANGER | ||
| U-2-OS | Growth inhibition assay | IC50 = 23.6987 μM | SANGER | ||
| MKN7 | Growth inhibition assay | IC50 = 27.8562 μM | SANGER | ||
| SK-N-FI | Growth inhibition assay | IC50 = 39.7075 μM | SANGER | ||
| CAL-72 | Growth inhibition assay | IC50 = 46.7339 μM | SANGER | ||
| 点击查看更多细胞系数据 | |||||
生物活性
| 产品描述 | Mitomycin C (Ametycine) 是一种抗肿瘤类抗生素，通过抑制DNA合成发挥作用，用于治疗各种癌症。Mitomycin C 可诱导半胱氨酸蛋白酶依赖性和Fas/CD95非依赖性的 apoptosis。此产品为危化品（急性毒性/易燃/皮肤腐蚀），请在穿戴防护面罩、防护手套和防护服后使用。 | |
|---|---|---|
| 靶点 |
|
| 体外研究(In Vitro) | ||||
| 体外研究活性 | Mitomycin C，通过诱导DNA链间交联，物理性阻断DNA复制，重组和RNA转录。[1] Mitomycin C增强TRAIL-诱导的HCT116 (p53-/-)结肠癌细胞的凋亡，并通过死亡受体不依赖于JNK的上调使耐TRAIL的结肠癌细胞HT-29对细胞因子敏感。[2]在不同的人癌症细胞系中，如OVCAR-5 (卵巢)，HT-29 (结肠)，SK-N-MC (成神经细胞瘤)，HEP-2 (肝脏)，COLO-205 (结肠)，NIH-OVCAR-3 (卵巢)和A-549 (肺)，Mitomycin C表现出细胞毒性。[3] |
|||
|---|---|---|---|---|
| 实验图片 | 检测方法 | 检测指标 | 实验图片 | PMID |
| Western blot | PARP / Caspase 8 / Caspase 9 / Cleaved caspase-9 / Caspase 3 / Cleaved caspase-3 p-Akt / Akt / p-S6K / S6K / p-Jun / JNK Beclin 1 / p62 / ATG5 GRP78 / CHOP / Caspase-4 / Cleaved caspase-4 |
|
24901052 | |
| 体内研究(In Vivo) | ||
| 体内研究活性 | 作为浅表性膀胱肿瘤的临床首选，在大鼠膀胱肿瘤模型中，Mitomycin C (400 μM)显著预防膀胱肿瘤的生长。[4] |
|
|---|---|---|
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT04934540 | Recruiting | Bladder Cancer |
Chinese University of Hong Kong |
January 1 2020 | -- |
| NCT02199327 | Completed | Conjunctival Intraepithelial Neoplasia|Corneal Intraepithelial Neoplasia |
Coordinación de Investigación en Salud Mexico|Instituto Mexicano del Seguro Social|University of Guadalajara |
May 2014 | Phase 4 |
化学信息&溶解度
| 分子量 | 334.37 | 分子式 | C15H18N4O5 |
| CAS号 | 50-07-7 | SDF | Download Mitomycin C SDF |
| Smiles | CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N | ||
| 储存条件(自收到货起) | 3年 -20°C(避光) 粉状 | ||
|
体外溶解度 |
DMSO : 67 mg/mL ( (200.37 mM) ；DMSO吸湿会降低化合物溶解度，请使用新开封DMSO) Water : Insoluble Ethanol : Insoluble |
摩尔浓度计算器 |
|
体内溶解度 现配现用，请按从左到右的顺序依次添加，澄清后再加入下一溶剂 |
动物体内配方计算器 | ||||
实验计算
动物体内配方计算器（澄清溶液）
第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量）
mg/kg
g
μL
只
第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系Selleck为您提供正确的澄清溶液配方）
% DMSO
%
% Tween 80
% ddH2O
%DMSO
%
计算结果：
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于μL DMSO溶液（母液浓度mg/mL，注：如该浓度超过该批次药物DMSO溶解度，请先联系Selleck）；
体内配方配制方法：取μL DMSO母液，加入μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入μL ddH2O，混匀澄清。
体内配方配制方法：取μL DMSO母液，加入μL Corn oil，混匀澄清。
注意：1. 首先保证母液是澄清的；
2.一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
技术支持
在订购、运输、储存和使用我们的产品的任何阶段，您遇到的任何问题，均可以通过拨打我们的热线电话400-668-6834，或者技术支持邮箱tech@selleck.cn，直接联系到我们。我们会在24小时内尽快联系您。
如果有其他问题，请给我们留言。
* 必填项
Tags: buy Mitomycin C | Mitomycin C supplier | purchase Mitomycin C | Mitomycin C cost | Mitomycin C manufacturer | order Mitomycin C | Mitomycin C distributor
